Shares of Macfarlane Group PLC (LON:MACF – Get Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 66.10 and traded as low as GBX 65. Macfarlane Group shares last traded at GBX 65, with a volume of 91,533 shares.
Wall Street Analyst Weigh In
Separately, Shore Capital Group reaffirmed a “house stock” rating on shares of Macfarlane Group in a research report on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of GBX 120.
Check Out Our Latest Research Report on Macfarlane Group
Macfarlane Group Price Performance
Insider Buying and Selling at Macfarlane Group
In related news, insider Ivor Gray sold 19,680 shares of the stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of GBX 6, for a total transaction of £1,180.80. Also, insider Peter Atkinson sold 38,077 shares of Macfarlane Group stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of GBX 6, for a total value of £2,284.62. 2.24% of the stock is owned by insiders.
About Macfarlane Group
Macfarlane Group PLC, through its subsidiaries, designs, manufactures, and distributes protective packaging products to businesses in the United Kingdom and Europe. The company operates through Packaging Distribution and Manufacturing Operations segments. The Packaging Distribution segment distributes packaging materials in the United Kingdom, Ireland, and Europe. The Manufacturing Operations segment designs, manufactures, and assembles timber, corrugated, and foam-based packaging materials in the United Kingdom.
Featured Articles
- Five stocks we like better than Macfarlane Group
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Macfarlane Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Macfarlane Group and related companies with MarketBeat.com's FREE daily email newsletter.
